These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

213 related articles for article (PubMed ID: 21135137)

  • 1. Therapy-induced selective loss of leukemia-initiating activity in murine adult T cell leukemia.
    El Hajj H; El-Sabban M; Hasegawa H; Zaatari G; Ablain J; Saab ST; Janin A; Mahfouz R; Nasr R; Kfoury Y; Nicot C; Hermine O; Hall W; de Thé H; Bazarbachi A
    J Exp Med; 2010 Dec; 207(13):2785-92. PubMed ID: 21135137
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Controversies in targeted therapy of adult T cell leukemia/lymphoma: ON target or OFF target effects?
    Nasr R; El Hajj H; Kfoury Y; de Thé H; Hermine O; Bazarbachi A
    Viruses; 2011 Jun; 3(6):750-69. PubMed ID: 21994752
    [TBL] [Abstract][Full Text] [Related]  

  • 3. In vivo and in vitro treatment of HTLV-1 and HTLV-2 infected cells with arsenic trioxide and interferon-alpha.
    Mahieux R; Hermine O
    Leuk Lymphoma; 2005 Mar; 46(3):347-55. PubMed ID: 15621824
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Arsenic-interferon-alpha-triggered apoptosis in HTLV-I transformed cells is associated with tax down-regulation and reversal of NF-kappa B activation.
    El-Sabban ME; Nasr R; Dbaibo G; Hermine O; Abboushi N; Quignon F; Ameisen JC; Bex F; de Thé H; Bazarbachi A
    Blood; 2000 Oct; 96(8):2849-55. PubMed ID: 11023521
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Phase II trial of arsenic trioxide and alpha interferon in patients with relapsed/refractory adult T-cell leukemia/lymphoma.
    Hermine O; Dombret H; Poupon J; Arnulf B; Lefrère F; Rousselot P; Damaj G; Delarue R; Fermand JP; Brouet JC; Degos L; Varet B; de Thé H; Bazarbachi A
    Hematol J; 2004; 5(2):130-4. PubMed ID: 15048063
    [TBL] [Abstract][Full Text] [Related]  

  • 6. ATL response to arsenic/interferon therapy is triggered by SUMO/PML/RNF4-dependent Tax degradation.
    Dassouki Z; Sahin U; El Hajj H; Jollivet F; Kfoury Y; Lallemand-Breitenbach V; Hermine O; de Thé H; Bazarbachi A
    Blood; 2015 Jan; 125(3):474-82. PubMed ID: 25395419
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Phase 2 study of the efficacy and safety of the combination of arsenic trioxide, interferon alpha, and zidovudine in newly diagnosed chronic adult T-cell leukemia/lymphoma (ATL).
    Kchour G; Tarhini M; Kooshyar MM; El Hajj H; Wattel E; Mahmoudi M; Hatoum H; Rahimi H; Maleki M; Rafatpanah H; Rezaee SA; Yazdi MT; Shirdel A; de Thé H; Hermine O; Farid R; Bazarbachi A
    Blood; 2009 Jun; 113(26):6528-32. PubMed ID: 19411628
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Arsenic/interferon specifically reverses 2 distinct gene networks critical for the survival of HTLV-1-infected leukemic cells.
    Nasr R; Rosenwald A; El-Sabban ME; Arnulf B; Zalloua P; Lepelletier Y; Bex F; Hermine O; Staudt L; de Thé H; Bazarbachi A
    Blood; 2003 Jun; 101(11):4576-82. PubMed ID: 12560223
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Humoral hypercalcemia of malignancy: severe combined immunodeficient/beige mouse model of adult T-cell lymphoma independent of human T-cell lymphotropic virus type-1 tax expression.
    Richard V; Lairmore MD; Green PL; Feuer G; Erbe RS; Albrecht B; D'Souza C; Keller ET; Dai J; Rosol TJ
    Am J Pathol; 2001 Jun; 158(6):2219-28. PubMed ID: 11395400
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Human T-cell leukemia virus type I Tax genotype analysis in Okinawa, the southernmost and remotest islands of Japan: Different distributions compared with mainland Japan and the potential value for the prognosis of aggressive adult T-cell leukemia/lymphoma.
    Sakihama S; Saito M; Kuba-Miyara M; Tomoyose T; Taira N; Miyagi T; Hayashi M; Kinjo S; Nakachi S; Tedokon I; Nishi Y; Tamaki K; Morichika K; Uchihara JN; Morishima S; Karube KN; Tanaka Y; Masuzaki H; Fukushima T
    Leuk Res; 2017 Oct; 61():18-24. PubMed ID: 28866351
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inhibition of the SDF-1alpha-CXCR4 axis by the CXCR4 antagonist AMD3100 suppresses the migration of cultured cells from ATL patients and murine lymphoblastoid cells from HTLV-I Tax transgenic mice.
    Kawaguchi A; Orba Y; Kimura T; Iha H; Ogata M; Tsuji T; Ainai A; Sata T; Okamoto T; Hall WW; Sawa H; Hasegawa H
    Blood; 2009 Oct; 114(14):2961-8. PubMed ID: 19657116
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Suppression of Type I Interferon Production by Human T-Cell Leukemia Virus Type 1 Oncoprotein Tax through Inhibition of IRF3 Phosphorylation.
    Yuen CK; Chan CP; Fung SY; Wang PH; Wong WM; Tang HV; Yuen KS; Chan CP; Jin DY; Kok KH
    J Virol; 2016 Apr; 90(8):3902-3912. PubMed ID: 26819312
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Curcumin (diferuloylmethane) inhibits constitutive active NF-kappaB, leading to suppression of cell growth of human T-cell leukemia virus type I-infected T-cell lines and primary adult T-cell leukemia cells.
    Tomita M; Kawakami H; Uchihara JN; Okudaira T; Masuda M; Takasu N; Matsuda T; Ohta T; Tanaka Y; Ohshiro K; Mori N
    Int J Cancer; 2006 Feb; 118(3):765-72. PubMed ID: 16106398
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Adult T-cell leukemia-lymphoma as a viral disease: Subtypes based on viral aspects.
    Nosaka K; Matsuoka M
    Cancer Sci; 2021 May; 112(5):1688-1694. PubMed ID: 33630351
    [TBL] [Abstract][Full Text] [Related]  

  • 15. How I treat adult T-cell leukemia/lymphoma.
    Bazarbachi A; Suarez F; Fields P; Hermine O
    Blood; 2011 Aug; 118(7):1736-45. PubMed ID: 21673346
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Treatment of adult T-cell leukaemia/lymphoma: current strategy and future perspectives.
    Bazarbachi A; Hermine O
    Virus Res; 2001 Oct; 78(1-2):79-92. PubMed ID: 11520582
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The combination of arsenic, interferon-alpha, and zidovudine restores an "immunocompetent-like" cytokine expression profile in patients with adult T-cell leukemia lymphoma.
    Kchour G; Rezaee R; Farid R; Ghantous A; Rafatpanah H; Tarhini M; Kooshyar MM; El Hajj H; Berry F; Mortada M; Nasser R; Shirdel A; Dassouki Z; Ezzedine M; Rahimi H; Ghavamzadeh A; de Thé H; Hermine O; Mahmoudi M; Bazarbachi A
    Retrovirology; 2013 Aug; 10():91. PubMed ID: 23962110
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Expression of human inducible nitric oxide synthase gene in T-cell lines infected with human T-cell leukemia virus type-I and primary adult T-cell leukemia cells.
    Mori N; Nunokawa Y; Yamada Y; Ikeda S; Tomonaga M; Yamamoto N
    Blood; 1999 Oct; 94(8):2862-70. PubMed ID: 10515890
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Arsenic trioxide and the growth of human T-cell leukemia virus type I infected T-cell lines.
    Ishitsuka K; Hanada S; Uozumi K; Utsunomiya A; Arima T
    Leuk Lymphoma; 2000 May; 37(5-6):649-55. PubMed ID: 11042529
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Emodin and DHA potently increase arsenic trioxide interferon-alpha-induced cell death of HTLV-I-transformed cells by generation of reactive oxygen species and inhibition of Akt and AP-1.
    Brown M; Bellon M; Nicot C
    Blood; 2007 Feb; 109(4):1653-9. PubMed ID: 17077332
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.